Sanofi India Ltd

SANOFI

Company Profile

  • Business description

    Sanofi India Ltd is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It focuses on a range of therapeutic areas, including diabetes, cardiology, consumer healthcare, hospital, central nervous system, and anti-histamines, among others, and sells its products through independent distributors predominantly in India. The company's products are manufactured in different types of dosage forms, including tablets, capsules (hard and soft), Eye/Ear drops, ampoules, vials, creams, and ointments, and are marketed under different brand names such as Soframycin, Lantus, Cardace, Soliqua, Solian, Thyrogen, Telcite, Zolineg, etc. Geographically, the company generates a majority of its revenue from India, followed by Singapore, and other export markets.

  • Contact

    Saki Vihar Road
    Sanofi House, CTS Number 117-B
    L&T Business Park
    Powai
    MumbaiMH400072
    IND

    T: +91 2228032000

    https://www.sanofiindialtd.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    1,285

Stocks News & Analysis

stocks

Undervalued ASX share showing progress in global efforts

More clarity on the path forward in the UK.
stocks

Bookworm: Is this the secret to exceptional long-term returns?

Acceptance may be an investor’s best friend.
stocks

Unconventional wisdom: Are dividends the answers?

As investors toil in complexity the obvious solution may be the right one.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,955.9021.600.24%
CAC 407,834.5816.300.21%
DAX 4024,217.5078.43-0.32%
Dow JONES (US)44,901.92208.010.47%
FTSE 1009,120.3118.06-0.20%
HKSE25,579.40191.050.75%
NASDAQ21,108.3250.360.24%
Nikkei 22541,148.07308.16-0.74%
NZX 50 Index12,909.6956.230.44%
S&P 5006,388.6425.290.40%
S&P/ASX 2008,690.5023.600.27%
SSE Composite Index3,601.808.150.23%

Market Movers